DAVITA INC. (DVA) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, DAVITA INC.'s filing signal continuing positive.

DaVita Inc. is a leading global healthcare provider specializing in kidney care, operating a comprehensive platform that supports patients throughout their kidney health journey. The company provides dialysis and related lab services to approximately 200,500 patients in the U.S. across 2,657 outpatient centers, and serves an additional 94,500 patients in 585 centers across 14 countries internationally. DaVita also offers integrated kidney care and disease management services to over 75,000 patients in risk-based arrangements in the U.S. Its patient-centric model emphasizes clinical quality and innovation, aiming for better integrated care, improved outcomes, and lower costs. The company's U.S. dialysis business, which accounts for about 86% of consolidated revenues, is primarily driven by treatment volumes and average patient service revenue per treatment, with government programs like Medicare and Medicaid being the largest payor sources.

Revenue is primarily driven by the volume of dialysis treatments and the average patient service revenue per treatment. Key factors influencing revenue include the mix of patients covered by commercial insurance versus government programs (Medicare, Medicaid), and the reimbursement rates set by these payors.